Success Metrics

Clinical Success Rate

100.0%

Based on 3 completed trials

Completion Rate

100%(3/3)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph phase_1

75%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

3(75.0%)

Phase 2Efficacy & side effects

1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(3)

Terminated(1)

Detailed Status

Completed3

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 2

Trials by Phase

Phase 13 (75.0%)

Phase 21 (25.0%)

Trials by Status

completed375%

withdrawn125%

Recent Activity

0 active trials

Showing 4 of 4

withdrawnphase_2

A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies

NCT03592862

completedphase_1

Clinical Trials (4)

Showing 4 of 4 trials

NCT03592862Phase 2

A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies

Withdrawn

NCT03456349Phase 1

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

Completed

NCT03198624Phase 1

Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects

Completed

NCT02958696Phase 1

Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4